When: Wednesday, October 15, 2003
9:00 a.m. - 3:00 p.m.
Where: Molecular Biology Building Atrium
Why: Discover opportunities in biotechnology!

ViraQuest, Inc.

ViraQuest, Inc. is a biotechnology company specializing in the production of adenoviral vectors and retains the exclusive commercial rights to RAPAdŽ technology. Using the patent pending processes unique to RAPAdŽ we can provide the fastest turn around time of any supplier in the industry. Utilizing the RAPAdŽ technology combined with easy subcloning steps results in production of your custom adenovirus particles in as little as three weeks without complications of revertants.